ArticleTranslational lung cancer research2024

A potential central nervous system niche for trastuzumab deruxtecan in patients with HER2-expressing non-small cell lung cancer.

Anna-Maria Lazaratos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.